CIS
UTMD icon

Connors Investor Services’s Utah Medical Products UTMD Stock Holding History

Connors Investor Services’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,243
Closed -$248K – 194
2015
Q4 		$248K Hold
4,243
– – 0.05% 125
2015
Q3 		$229K Buy
4,243
+652
+18% +$35.6K 0.05% 130
2015
Q2 		$214K Hold
3,591
– – 0.04% 139
2015
Q1 		$215K Hold
3,591
– – 0.05% 146
2014
Q4 		$216K Buy
+3,591
New +$199K 0.05% 138
2014
Q2 		– Sell
-3,591
Closed -$208K – 151
2014
Q1 		$208K Buy
+3,591
New +$196K 0.05% 134

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MDCM
Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Connors Investor Services's UTMD Position: Q1 2016 in Review

Connors Investor Services sold out of Utah Medical Products (UTMD) in Q1 2016, closing a stake of 4,243 shares — an estimated $248K sold.

Connors Investor Services first reported a position in UTMD in Q1 2014 and held it in 6 quarters. The position peaked at $248K in Q4 2015. 68 funds tracked by Wall St. Rank hold UTMD as of Q1 2016.

  • Connors Investor Services reported no remaining Utah Medical Products position as of Q1 2016 after selling out during the quarter.
  • Connors Investor Services sold 4,243 Utah Medical Products shares in Q1 2016, an estimated $248K.
  • Connors Investor Services first reported a position in Utah Medical Products in Q1 2014 and held it in 6 quarters.
  • Connors Investor Services's Utah Medical Products position peaked at $248K in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2016.

Based on Connors Investor Services's 13F filing for Q1 2016, filed 12 May 2016.